IDEXX Laboratories stock gains as revenue outlook meets premium valuation

Published on 09/23/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IDEXX Laboratories stock closed at USD 517.57 on September 21, 2026, up 1.16 percent. Projected 2026 revenue is USD 4.6 billion against a 35.96 P/E ratio.

Moderne Veterinärdiagnostik-Labor mit Analysegeräten, Blutproben und Technikerin — IDEXX Laboratories US45168D1046 zeigt ein modernes Veterinärdiagnostik Labor mit Analysegeräten und Technikerin, Illustration mit AI erstellt.

IDEXX Laboratories stock (ISIN US45168D1046) closed at USD 517.57 on Nasdaq on September 21, 2026, gaining 1.16 percent from the previous session. A September 22, 2026 market snapshot put the shares at USD 522.81, with a market capitalization of USD 40.60 billion and volume of 508,758 shares.

Revenue outlook supports valuation

According to AD HOC NEWS on September 22, 2026, IDEXX Laboratories generated revenue of USD 4.3 billion in fiscal year 2025 and was projected to reach USD 4.6 billion in 2026. The USD 0.3 billion increase represents about 7.0 percent growth, while the same report cited raised 2026 EPS guidance and a projected 2026 net income margin of 24.61 percent.

The operating comparison matters because the valuation remains elevated. A price-to-earnings ratio of 35.96 on September 22, 2026 places a premium on continued earnings delivery rather than revenue expansion alone.

52 week range shows technical pressure

The September 22, 2026 snapshot showed a 52-week range of USD 504.70 to USD 766.68. At USD 522.81, the shares were USD 18.11 above the yearly low and USD 243.87 below the yearly high, leaving the stock much closer to the lower boundary than the upper one.

The same September 22, 2026 data cited a consensus price target of USD 665 based on 13 buy ratings. That target was USD 142.19 above the comparison price of USD 522.81, while insider selling and technical weakness were identified as counter-factors.

Nasdaq price stays above yearly low

IDEXX Laboratories closed at USD 517.57 on Nasdaq on September 21, 2026, up 1.16 percent from the prior session. The separate September 22, 2026 snapshot recorded USD 522.81, market capitalization of USD 40.60 billion and volume of 508,758 shares.